Class / Patent application number | Description | Number of patent applications / Date published |
514400700 | Lactation affecting | 11 |
20110172146 | GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME - The present invention relates to compositions comprising growth hormone linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in administration to animals. | 07-14-2011 |
20110212886 | PHARMACEUTICAL COMPOSITIONS COMPRISING CASEIN DERIVED PEPTIDES AND METHODS OF USE THEREOF - The present invention relates to peptides derived from casein and their use in the management of lactating animals, particularly to methods for decreasing the length of the dry period of a lactating livestock animal, for increasing its milk yield and milk hygiene after parturition and for improving the livestock welfare. The present invention further relates to pharmaceutical compositions comprising peptides derived from casein in the form of a sterile solution, which compositions are clear and substantially devoid of micelles. | 09-01-2011 |
20120214733 | OXYTOCIN RECEPTOR AGONISTS - The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification: | 08-23-2012 |
20130012431 | Method For Elevating Prolactin In Mammals - Methods for elevating and stabilizing prolactin levels in a mammal including methods of treating disorders and conditions associated with reduced serum levels of prolactin are provided. Also provided are methods of using certain synthetic tetrapeptide amides which are peripherally selective kappa opioid receptor agonists to elevate or stabilize serum prolactin levels. | 01-10-2013 |
20130040876 | METHOD FOR SENSITIZING CELLS TO CANCER THERAPY - Disclosed herein are compositions and methods useful for the treatment of cancer, such as breast cancer. In some embodiments, the methods and compositions include human prolactin, or human prolactin in conjunction with a cytotoxic agent. In other embodiments, the methods and compositions include one or more of human prolactin, growth hormone and placental lactogen, or one or more of human prolactin, growth hormone and placental lactogen in conjunction with a cytotoxic agent. In some embodiments, the cytotoxic agent comprises a chemotherapeutic agent. | 02-14-2013 |
20130172241 | METHOD FOR PROCESSING PROLAMIN-CONTAINING FEED FOR A RUMINANT ANIMAL TO POTENTIATE MILK PRODUCTION OR CONCEPTION - Composition and method for processing prolamin-containing feed source into a low-vitreous gelatinous feedstuff. The feedstuff is fed to ruminant animals for the purpose of potentiating either milk production and/or conception. The feed source can be corn and the ruminant animal can be a bovine, and might be a cow. The method includes processing, by extrusion, a prolamin-containing feed source having a starch-protein matrix within which the included protein is composed of at least 3% percent prolamin. This processing produces a hydrophilic gelatinous feedstuff that has starch and protein content. The hydrophilic low-vitreous gelatinous feedstuff is fed to a ruminant animal. A rumen-retained portion of the fed feedstuff is retained within the rumen of the animal for at least a twenty-four hour period, and during the first twenty-four hours of that period, at least seventy-five percent of the starch content of the rumen-retained portion of the fed feedstuff is digested. | 07-04-2013 |
20140171360 | NUTRITIONAL SUPPLEMENT, METHOD FOR INCREASING THE BACTERIAL MASS IN THE RUMEN OF A RUMINANT AND NUTRITIONAL PREPARATION AND CORRESPONDING USES - A nutritional supplement, a method for increasing the bacterial mass in the rumen of a ruminant and a nutritional preparation and corresponding uses. A nutritional supplement including proteins with a degree of hydrolysis above 28% and/or which have more than 23 mg α-amino nitrogen per gram of protein and/or have more than 10% of free amino acids. The hydrolyzed proteins are animal proteins, preferably hemoglobin. The supplement is supplied orally, included in a nutritional preparation, in liquid, concentrated or dehydrated form. The supplement is the basis for a method of increasing the bacterial mass in the rumen of a ruminant in which there is added to the ruminant's diet a supplement with these hydrolyzed proteins | 06-19-2014 |
20140221277 | Method For Elevating Prolactin In Mammals - Methods for elevating and stabilizing prolactin levels in a mammal including methods of treating disorders and conditions associated with reduced serum levels of prolactin are provided. Also provided are methods of using certain synthetic tetrapeptide amides which are peripherally selective kappa opioid receptor agonists to elevate or stabilize serum prolactin levels. | 08-07-2014 |
20140274886 | METHODS AND SYSTEMS FOR ADJUSTING RUMEN UNDEGRADED PROTEIN IN ANIMAL DIETS - In a ruminant feed, rumen undegraded protein (“RUP”), which is protein orally ingested and passed through the rumen in an undegraded or undigested state, is determined through analysis of feed components in the feed and is used to modify the feed formulation to control a level of RUP exiting the rumen of the ruminant. Additionally the RUP and rumen undegraded neutral detergent fiber (“RUNDF”) content of selected feed components may be received based on an analysis of the feed components and the feed ration may be formulated accordingly. The RUP content may be determined by comparing analysis results with a calibration curve of previously analyzed feed components. | 09-18-2014 |
20150313957 | Chemical Induction Of Lactation In Male Non-Human Mammals - The present invention describes a method of inducing lactation in non-human mammals by using a single administrations of an estrogen compound, a dopaminergic antagonist, and oxytocin. For example, the estrogen compound may be a long acting composition and is administered at least one week before the dopaminergic antagonist. However, the oxytocin administration may be given the day after the dopaminergic antagonist, after which lactation may begin immediately. Preferred compounds may comprise a non-17β estradiol and domperidone. Such an injection protocol has resulted in the production of commercially viable volumes of milk from transgenic pigs. | 11-05-2015 |
20160183554 | USE OF NUTRITIONAL SUPPLEMENT FOR INCREASING THE BACTERIAL MASS IN THE RUMEN OF A RUMINANT - Use of a nutritional supplement for increasing the bacterial mass in the rumen of a ruminant. The nutritional supplement includes proteins with a degree of hydrolysis above 28% and has more than 23 mg α-amino nitrogen per gram of protein. The hydrolyzed proteins are preferably hemoglobin. | 06-30-2016 |